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After antigen recognition by its receptor, the naïve B cell migrates to the border of the T cell zone 
where it receives signals to proliferate and originates several types of effector cells, such as antibody 
secreting plasma cells, germinal center (GC) cells and GC-independent memory cells. The question 
of whether a single naïve B cell has the potential to give rise to all three of these effector cells or is 
already committed to a specific path is central for vaccine development. 
In an article published on Science, Dr. Justin Taylor from the Vaccine and Infectious Disease 
Division (VIDD) at Fred Hutch follows the fascinating path of a single naïve B cell after antigen 
recognition. The results showed immense heterogeneity in the progeny of different B cells. In 44% of 
cases, a single cell originated a single effector cell subset (plasma cells, GC cells, GC-independent 
memory cells or activated precursor cells). Only 4 out of 74 clonal population contained all the 
subsets and the rest 2-3 subsets. Not surprisingly, large clonal populations were more likely to give 
rise to multiple subsets. Surprisingly however, no relationship was observed between the size of the 
clonal population and the capacity to proliferate. Dr. Taylor and his colleagues hypothesized that the 
size of the responding population was related to the ability of a clonal population to resist apoptosis. 
Indeed, single B cells resistant to apoptosis by genetic knockout of the pro-apoptotic mediator Bim 
carried the potential to generate a bigger population of effector cells and were more likely to 
generate multiple subsets. 
Previous research had suggested that another factor influencing the fate of a naïve B cell is the 
affinity of the receptor for the antigen. To test this hypothesis, the response of transgenic B cells to 
high or medium affinity antigen were compared. Stimulation with high affinity antigen resulted in the 
preferential production of plasma cells and GC cells, and fewer GC-independent memory cells as 
compared to the medium affinity stimulated clones. This role that receptor affinity for antigen plays in 
effector cell differentiation is similar to recent findings with T cells. 
This study represents a milestone in B cell and vaccine research. As Dr. Taylor puts it, "The 
implication of our work is that not every B cell stimulated by a vaccine is going to respond the way 
that we want it to.  What we need to do is figure out how to ensure that the most useful B cells resist 
apoptosis and differentiate down the pathway that will yield a long-lived protective response." 
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Schematic representation of the optimal B cell response to 
vaccination, on the left, and actual response, on the right. 
 
